Why Is Nektar Therapeutics (NKTR) Stock Down 39% Today?
| InvestorPlace • February 24, 2023, 1:56 pm
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Nektar Therapeutics (NKTR) stock is taking a beating on Friday following the release of poor Phase 2 clinical trial data.
The post Why…
| InvestorPlace • February 24, 2023, 2:10 pm
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
These three top EV stocks should certainly make the watch list for long-term growth investors seeking outperformance.
The post 3 Top EV…
Comments
Post a Comment